Nuo Therapeutics Inc (NUOTQ)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Nuo Therapeutics Inc (NUOTQ) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011143
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nuo Therapeutics Inc (Nuo Therapeutics) is a biomedical company, which specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural healing. The company’s flagship product, Aurix System, is a biodynamic hematogel designed to harness a patient’s innate regenerative abilities to manage a wide range of wounds. Aurix is US FDA approved platelet and plasma therapy system for managing a wide range of ulcers and exuding wounds, including leg ulcer, diabetic ulcer, pressure ulcer, and all severities such as full thickness, partial thickness and complex wounds. The company has an office in Nashville, Tennessee; and a facility in Durham, North Carolina. Nuo Therapeutics is headquartered in Gaithersburg, Maryland, the US.

Nuo Therapeutics Inc (NUOTQ) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nuo Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Nuo Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Nuo Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Nuo Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Nuo Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Nuo Therapeutics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Aldagen Raises Additional US$0.06 Million In Venture Financing 10
Partnerships 11
Boyalife Enters into Licensing Agreement with Nuo Therapeutics for Aurix System 11
Rohto Pharma Enters into Licensing Agreement with Nuo Therapeutics 12
Nuo Therapeutics Amends Licensing Agreement with Arthrex 13
Equity Offering 14
Nuo Therapeutics to Raise up to USD11.6 Million in Public Offering of Shares 14
Nuo Therapeutics Raises USD7.5 Million in First Tranche of Private Placement 16
Nuo Therapeutics Raises USD7.3 million in Public Offering of Shares 17
Nuo Therapeutics Raises USD2 Million in Private Placement of Shares 18
Cytomedix Completes Private Placement Of Shares For US$7 Million 19
Cytomedix Files Registration Statement For Public Offering Of Securities For Up To US$35 Million 20
Cytomedix Completes Private Placement Of US$0.32 Million 21
Acquisition 22
Cytomedix Acquires Developer Of Regenerative Cell Therapies, Aldagen 22
Nuo Therapeutics Inc – Key Competitors 24
Nuo Therapeutics Inc – Key Employees 25
Nuo Therapeutics Inc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Corporate Communications 27
Jan 12, 2016: Nuo Therapeutics Announces Senior Management Change and Provides Limited Corporate Update 27
Legal and Regulatory 28
Jul 05, 2017: Nuo Therapeutics Receives Advisory Opinion Waiver for Medicare Part B Co-Payments for Patients in Aurix CED Clinical Studies 28
Mar 29, 2016: Nuo Therapeutics Provides Update on Chapter 11 Bankruptcy Process and Proposed Plan of Reorganization 29
Jan 26, 2016: Nuo Therapeutics Commences Voluntary Chapter 11 Business Reorganization 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Nuo Therapeutics Inc, Medical Equipment, Key Facts, 2016 2
Nuo Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Nuo Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Nuo Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Nuo Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Nuo Therapeutics Inc, Deals By Market, 2011 to YTD 2017 8
Nuo Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Aldagen Raises Additional US$0.06 Million In Venture Financing 10
Boyalife Enters into Licensing Agreement with Nuo Therapeutics for Aurix System 11
Rohto Pharma Enters into Licensing Agreement with Nuo Therapeutics 12
Nuo Therapeutics Amends Licensing Agreement with Arthrex 13
Nuo Therapeutics to Raise up to USD11.6 Million in Public Offering of Shares 14
Nuo Therapeutics Raises USD7.5 Million in First Tranche of Private Placement 16
Nuo Therapeutics Raises USD7.3 million in Public Offering of Shares 17
Nuo Therapeutics Raises USD2 Million in Private Placement of Shares 18
Cytomedix Completes Private Placement Of Shares For US$7 Million 19
Cytomedix Files Registration Statement For Public Offering Of Securities For Up To US$35 Million 20
Cytomedix Completes Private Placement Of US$0.32 Million 21
Cytomedix Acquires Developer Of Regenerative Cell Therapies, Aldagen 22
Nuo Therapeutics Inc, Key Competitors 24
Nuo Therapeutics Inc, Key Employees 25
Nuo Therapeutics Inc, Other Locations 26
Nuo Therapeutics Inc, Subsidiaries 26

★海外企業調査レポート[Nuo Therapeutics Inc (NUOTQ)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Xped Ltd (XPE):石油・ガス:M&Aディール及び事業提携情報
    Summary Xped Ltd (Xped) formerly Raya Group Limited, is an Internet of Things company that develops software and hardware solutions. It offers auto discovery remote control, Xerts, and Xped app software; and hardware such as Xped ADRC Shields, Umbo-Xped ADRC Hub, UltraPlug, VariPlug, IRBlaster. The …
  • Eutelsat Communications S.A. (ETL):企業の財務・戦略的SWOT分析
    Eutelsat Communications S.A. (ETL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • International Zeolite Corp:企業の戦略・SWOT・財務分析
    International Zeolite Corp - Strategy, SWOT and Corporate Finance Report Summary International Zeolite Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Protagonist Therapeutics Inc (PTGX):企業の財務・戦略的SWOT分析
    Protagonist Therapeutics Inc (PTGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Ballast Nedam NV:企業の戦略・SWOT・財務情報
    Ballast Nedam NV - Strategy, SWOT and Corporate Finance Report Summary Ballast Nedam NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sentara Healthcare Inc:企業の戦略的SWOT分析
    Sentara Healthcare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Siemens Healthineers AG (SHL):企業の財務・戦略的SWOT分析
    Siemens Healthineers AG (SHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Osmotica Pharmaceutical Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Osmotica Pharmaceutical Corp (Osmotica) is a pharmaceutical company that specializes in drug delivery technologies and neurology based therapies. The company provides product portfolio such as nifedipine, oxybutynin, venlafaxine and desvenlafaxine, among others. It offers capabilities such a …
  • Sumol+Compal SA:企業の戦略・SWOT・財務情報
    Sumol+Compal SA - Strategy, SWOT and Corporate Finance Report Summary Sumol+Compal SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Sumitomo Dainippon Pharma Co Ltd (4506):製薬・医療:M&Aディール及び事業提携情報
    Summary Sumitomo Dainippon Pharma Co Ltd (Sumitomo Dainippon), a subsidiary of Sumitomo Chemical Co., Ltd, develops manufacturers, purchases, sells, imports and exports pharmaceutical products. The company focuses on major therapeutic areas which include central nervous system (CNS), cardiovascular, …
  • EnergyAustralia Pty Ltd:電力:M&Aディール及び事業提携情報
    Summary EnergyAustralia Pty Ltd (EnergyAustralia), formerly TRUenergy, is an electric utility that invests in energy generation and retailing activities. The company generates electricity and retails power and gas. It produces electricity from coal, gas, solar and wind sources. EnergyAustralia offer …
  • Al Salam Bank BSC (SALAM):企業の財務・戦略的SWOT分析
    Al Salam Bank BSC (SALAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Mahaweli Reach Hotels Plc:企業の戦略・SWOT・財務分析
    Mahaweli Reach Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary Mahaweli Reach Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Muscatine Power and Water:発電所・企業SWOT分析
    Muscatine Power and Water - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Walchandnagar Industries Ltd:企業の戦略・SWOT・財務分析
    Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Investment Technology Group, Inc.:企業の戦略・SWOT・財務情報
    Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Investment Technology Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Taikisha Ltd:企業の戦略・SWOT・財務分析
    Taikisha Ltd - Strategy, SWOT and Corporate Finance Report Summary Taikisha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Dominion Resources Inc:発電所・企業SWOT分析
    Dominion Resources Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employ …
  • Genpact Ltd:企業の戦略・SWOT・財務情報
    Genpact Ltd - Strategy, SWOT and Corporate Finance Report Summary Genpact Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Opus Energy Group Ltd:企業の戦略的SWOT分析
    Opus Energy Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆